… angiotensin-converting–enzyme (ACE) inhibitors at reducing fatal and nonfatal cardiovascular
… an ARB if it is as effective as an ACE inhibitor but better tolerated or less costly. However, …

… of action of ACE inhibitors remains incompletely understood. … with ACE inhibitors may
reduce the risk of cardiovascular … benefits of ACE inhibitors — in this case, ramipril — exceed …

… these drugs beneficial in other cardiac diseases, such as cardiac hypertrophy, myocardial
ischemia, … on cardiac and renal protection and prevention of heart failure. ACE INHIBITORS IN …

… Cardiovascular disease is the leading cause of mortality worldwide, affecting a wide range
of patients at different stages across the cardiovascular continuum. Hypertension is one of the …

… risk factors for cardiovascular disease and angiographically proven … Interestingly, the beneficial
effect of ACE inhibition on … , so the effects of ACE inhibition on endothelial dysfunction in …

… cardiovascular disease, renal disease progression, and stroke. This article explores potential
mechanism by which ACE inhibition … reduces cardiovascular disease and renal disease. …

… Treatment with ACE inhibitors or ARBs is recommended in both hypertension and cardiovascular
diseases, particularly in diabetic patients. The use of ACE inhibitors is recommended …

… a major role in cardiovascular disease and during the past … of the use of angiotensin converting
enzyme inhibitors (ACE-I) in … for the use of ACE-I in patients with cardiovascular disease. …

… events with Perindopril in stable coronary Artery disease (EUROPA) and Perindopril … and
prevents cardiovascular disease in a large range of patients with vascular diseases, whether …

… with established cardiovascular disease should be treated with ACE-inhibitors? … ACEinhibitor.
In clinical practice, these will probably be patients with established cardiovascular disease …